A Study of XMT-1660 in Participants With Solid Tumors

Status:
Not yet recruiting

Trial end date:
2026-01-01

Target enrollment:

Participant gender:

A Study of XMT-1660 in Solid Tumors

Phase 1

Mersana Therapeutics